Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PULMONX CORPORATION (LUNG) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PULMONX CORPORATION (LUNG), most recent 12 months reported: revenue $87.44M, net loss $48.12M, free cash flow -$30.67M. Latest balance sheet on file: liquid cash $55.84M, total debt $37.53M, net cash $18.31M. From SEC filings. Others in Surgical & Medical Instruments & Apparatus: XTANT MEDICAL HOLDINGS, INC. · Kestra Medical Technologies, Ltd. · NEUROPACE, INC. · DELCATH SYSTEMS, INC. · IRADIMED CORPORATION · SIGHT SCIENCES, INC. · TELA Bio, Inc. · PRO-DEX, INC.

Stock screener

Watchlist